Managing GLP-1 Medications in Sleep Medicine: Clinical Strategies and Best Practices

Sleep medicine clinicians address GLP-1 weight-loss drug questions

Clinicians in sleep medicine are fielding a rising number of patient inquiries regarding glucagon-like peptide-1 receptor agonists as new connections emerge between body weight and sleep disorders.

Key Clinical Takeaways:

• The American Academy of Sleep Medicine hosted a webinar to help clinicians safely manage obesity pharmacotherapy in patients with sleep disorders.
• Specialists introduced a 6-step framework to assess, advise, and monitor patients initiating medications like tirzepatide.
• Experts emphasize that substantial weight loss does not automatically eliminate the need for positive airway pressure therapy.

Webinar outlines obesity pharmacotherapy strategies

The American Academy of Sleep Medicine hosted a webinar titled “The Good, the Bad and the Manageable: Practical Pearls for Obesity Pharmacotherapy in Sleep Medicine” to help professionals provide safe care.

Dr. Xinhang Tu of the University of Michigan moderated the session. Panelists included Dr. Mira Tadros of the Icahn School of Medicine at Mount Sinai, Dr. Safia Khan of UT Southwestern Medical Center, and Dr. Nicollas Mozart Vieira of Instituto Mozart.

Tu outlined three primary focal points for the discussion. Clinicians examined pre-treatment patient assessments, the practical mechanics of treatment, and lifestyle recommendations alongside medication management.

Tadros uses sample patient to demonstrate clinical workflow

To demonstrate the clinical workflow, Tadros introduced a sample patient named Alex. The 50-year-old man presents with a body mass index of 40, hypertension, prediabetes, and obstructive sleep apnea. While Alex manages his condition with positive airway pressure therapy, he struggles to maintain weight loss through lifestyle changes alone and inquired about GLP-1 therapy.

Tadros highlighted the “6 As framework” for managing obesity in sleep medicine. The steps involve asking permission to discuss weight, assessing health risks, advising on personalized strategies, agreeing on interventions, assisting with multidisciplinary support, and arranging follow-up care.

Often, patients who have been living with obesity might have had difficult discussions in healthcare, or just have experienced bias and stigma before, so just introducing the topic … is a huge thing, Tadros said.

Obesity medications are generally recommended for patients with a body mass index greater than 30, or above 27 with weight-related comorbidities. Tadros advised baseline bloodwork as a best practice before beginning tirzepatide.

Managing dosage adjustments and early side effects

Khan evaluated Alex’s progress at four weeks into his regimen. The patient lost approximately 3 percent of his body weight while experiencing early satiety and occasional nausea.

We also should monitor waist circumference, blood pressure and glycemia, Khan said. Clinicians must distinguish normal satiety from adverse effects such as vomiting, diarrhea, or constipation.

When side effects become pronounced, pausing dose escalation is appropriate. Khan noted that staying on a tolerated dose for longer than four to six weeks remains viable if patients achieve consistent weight loss.

Evaluating continued positive airway pressure needs

Following consistent weight loss, Alex asked whether he could discontinue his continuous positive airway pressure machine. Tu stressed that dropping weight does not guarantee the resolution of sleep apnea.

The key point is that the weight loss does not automatically mean the resolution of sleep apnea, Tu said. Clinicians should evaluate the complete clinical picture and symptoms before adjusting pressure settings or considering alternative therapies.

Vieira discusses long-term nutritional support strategies

Vieira discussed long-term support strategies for patients using GLP-1 medications. Because reduced food intake can introduce nutritional gaps, prioritizing macronutrients and micronutrients is essential.

Usually, the best diet is the one that the patient can maintain the longest, Vieira said. Referral to a registered dietitian and tracking food intake via diaries or applications can help maintain nutritional balance.

Tu reiterated that comprehensive obesity treatment extends well beyond prescription management. The American Academy of Sleep Medicine’s Obesity Management Task Force provides ongoing guidance and clinical resources for integrating obesity care into sleep medicine practices.

Disclaimer: The information provided in this article is for educational and scientific communication purposes only and does not constitute medical advice. Always consult with a qualified healthcare provider regarding any medical condition, diagnosis, or treatment plan.